戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1664086作成日:2026年10月23日

Adipic Dihydrazide → Amikacin

https://huagongshe.com/ja/reaction/1664086

反応式

関与物質

役割名称HCID仕込み量
反応物Adipic DihydrazideHCID 66117—
反応物Amikacin Sulfate SaltHCID 5458175—
反応物(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol sulfateHCID 86619106—
反応物(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide sulfateHCID 86619108—
反応物tobramycin sulfate clindamycin HClHCID 131729235—
生成物AmikacinHCID 37768—

反応手順

Amikacin Sulfate (100 mg), DBM (200 mg), and 8 mg of adipic acid dihydrazide were placed into a beaker and mixed thoroughly. Oxidized dextran solution (Mw, 500,000; 66 mg/ml; 1 ml) was added to the mixture. Tobramycin-sulfate or tobramycin-sulfate/clindamycin-HCl (1/1) can be used in place of amikacin-sulfate.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US08039021B2
出典データセットuspto-grants-2011_10
ORD IDord-f1c377f4273646c9a4a40597dec3cc2f
出典メモuspto-grants-2011_10